Document is current

Article History

Received: 19 January 2026

Accepted: 19 May 2026

First Online: 30 June 2026

Declarations

:

: Vaia Lambadiari has received honoraria in the context of Advisory Boards, research grants, clinical trials, speakers bureau, and consultancy by Novartis, Sanofi, Novo Nordisk, MSD, Eli Lilly, Boehringer, Vianex, AstraZeneca, Mylan, Amgen, Elpen, Amryt, Medtronic, Menarini, Bios, and Abbott. Andriani Vazeou has received funding for conference attendance from Novo Nordisk, Eli Lilly, Medtronic, and Abbott. Athanasios Christoforidis has received educational grants from Medtronic. Konstantinos Makrilakis has provided advisory board services and has received grant support and fees for consultancy from AstraZeneca, Boehringer Ingelheim, Lilly, Novo Nordisk, GSK, Sanofi, Medtronic, Hemoglobe, and Menarini. Maria-Joanna Juachon, Vittorino Smaniotto, Tim van den Heuvel, and Goran Petrovski are employees of Medtronic. Nikolaos Tentolouris, Christina Kanaka-Gantenbein, and Triantafyllos Didangelos have nothing to disclose.

: The study was conducted in accordance with the Declaration of Helsinki (1964) and its subsequent amendments. Ethics committee approval was not required for this study as this study was a real-world analysis and therefore deemed to not qualify as “human subjects research." All CareLink™ Personal account holders are proactively asked to provide consent for the use of their de-identified data by Medtronic for research purposes. Users who did not provide consent were excluded from the analyses, and all data were analyzed only after de-identification.